Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 691 publications
Therapeutic Advances in Neurofibromatosis Type 1: A Focus on Selumetinib.
Journal: Skin therapy letter
Published: September 24, 2025
RNF135 Expression Marks Chemokine (C-C Motif) Ligand-Enriched Macrophage-Tumor Interactions in the Glioblastoma Microenvironment.
Journal: Cancers
Published: August 28, 2025
Integrative Genomic and Immune Profiling to Identify and Characterize High-Risk Subgroups in Acute Myeloid Leukemia: Development of a 20-Gene Predictive Signature and Its Clinical Implications.
Journal: Omics : a journal of integrative biology
Published: August 22, 2025
Visual Improvement in a Child With Periorbital Plexiform Neurofibroma Treated With Selumetinib: Case Report and Literature Review.
Journal: Ophthalmic plastic and reconstructive surgery
Published: August 11, 2025
Targeted therapy combinations with ipatasertib in multi-cell type 3D tumor spheroid models.
Journal: Academia oncology
Published: August 05, 2025
Long-term Ocular Safety in Children Treated with MAPK Pathway Inhibitor Therapy.
Journal: Ophthalmology
Published: August 02, 2025
Selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma: Propensity score analysis of SPRINT vs. natural history control arm.
Journal: Neuro-oncology advances
Published: July 25, 2025
Computational profiling and virtual screening of MEK inhibitors for triple-negative breast cancer therapy.
Journal: In silico pharmacology
Published: July 23, 2025
Evaluating Potential Therapeutic Targets and Drug Repurposing Based on the Esophageal Cancer Subtypes.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 16, 2025
Selumetinib for Adults with NF1-Associated Plexiform Neurofibromas: Insights from the KOMET Study.
Journal: Neuro-oncology
Published: July 11, 2025
Comment on: "selumetinib use as targeted therapy for plexiform neurofibroma: a comprehensive review of the literature" - mirdametinib as the emerging standard in NF1-PN.
Journal: Orbit (Amsterdam, Netherlands)
Published: July 09, 2025
A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 30, 2025
Last Updated: 10/31/2025